XLO Quarterly Net Margin
-619.53%
-28.74%-4.86%
30 September 2024
Summary:
As of January 22, 2025, XLO quarterly net profit margin is -619.53%, with the most recent change of -28.74% (-4.86%) on September 30, 2024. XLO quarterly net margin is now -4.86% below its all-time high of -590.79%, reached on June 30, 2024.XLO Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XLO Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
XLO Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.9% | at low | ||
| 5 y | 5-year | -4.9% | at low | ||
| alltime | all time | -4.9% | at low |
Xilio Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -619.53%(+4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -590.79% |
FAQ
- What is Xilio Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Xilio Therapeutics?
What is Xilio Therapeutics quarterly net profit margin?
The current quarterly net margin of XLO is -619.53%
What is the all time high quarterly net margin for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly net profit margin is -590.79%